Newsletter | January 28, 2025

01.28.25 -- 2024 Survey Findings: How Is The "Lab Of The Future" Becoming Reality?

FEATURED EDITORIAL

2024 Survey Findings: How Is The "Lab Of The Future" Becoming Reality?

The Pistoia Alliance conducted a survey as a pulse check on which technologies the pharma/biotech industry is investing in and companies' progress integrating new tech into the lab.

INDUSTRY INSIGHTS

Developing And Scaling Through Innovative Technologies

Watch as Cambrex experts walk through a variety of technologies and case studies, focusing on LPPS, peptide crystallization, method development for peptide impurity analysis, and more.

Efficient Measurement Of Critical Quality Attributes And Parameters

Gain insight into the use of a promising alternative to assays performed utilizing traditional, time- and labor-intensive techniques for various CQA applications across drug discovery and development.

Exploring Neuroinflammation, Neurodegeneration With A Brain Organ-Chip

Examine how Organ-on-a-Chip technology, accurately mimicking human neuroinflammation, offers promising human-relevant avenues for neurodegenerative disease research.

Solutions For Accelerated Pharmaceutical Development

Explore an integrated service package designed to simplify and accelerate the development pathway, even for APIs with challenging properties such as low aqueous solubility and poor bioavailability.

Spray-Dried Bevacizumab: Treating Non-Small Cell Lung Cancer

The development of physically stable, biologically active dry powder formulations of large molecules for inhalation has remained a challenge.

5 Considerations For Buffer Optimization During Biologics Pre-Formulation

Formulation development is a vital part of the drug development process. Explore key factors to consider in pre-formulation.

MOST POPULAR NEWS

MERIT Acquires OSOD, Expanding Capabilities In Early-Stage Drug Development

VALID Therapeutics Partners With Araceli Biosciences To Advance AI-Driven Drug Discovery

Evotec Receives Grant From Korean Govt To Develop Novel Antibody-Based Treatments

ArriVent BioPharma Enters Exclusive License With Lepu Biopharma For MRG007

Dyne Therapeutics Receives FDA Fast Track Designation For DYNE-101

ParityQC & The University Of Hamburg Joining Forces For The Ambitious New Project QuADro

Arrowhead Pharmaceuticals Announces Acceptance Of NDA By U.S. FDA Of Plozasiran

Zai Lab Announces Acceptance Of NDA For KarXT For The Treatment Of Schizophrenia

Structural Insights Reveal Drug Target In Trypanosome Parasites

ImmunoPrecise Antibodies Realigns Pipeline Strategy

U Of T Researchers Develop New Approach Using Quantum Computers

SOLUTIONS

Sampling And Dispensing Services

Curia

Achieving mRNA-LNP Delivery Beyond The Liver